MAGI3 and cancer: MIPEP expression was also significantly increased (p < 0.05) in grade II tumors comparing to the grade I. We also showed significantly (p < 0.05) and highly significant (p < 0.001) decreased expression of MAGI3 and ZFP37 (respectively) in the most malignant tumors (Table 3).